CN112999190B - A549细胞来源外泌体装载连翘酯苷a递药系统及其应用 - Google Patents
A549细胞来源外泌体装载连翘酯苷a递药系统及其应用 Download PDFInfo
- Publication number
- CN112999190B CN112999190B CN202110225171.4A CN202110225171A CN112999190B CN 112999190 B CN112999190 B CN 112999190B CN 202110225171 A CN202110225171 A CN 202110225171A CN 112999190 B CN112999190 B CN 112999190B
- Authority
- CN
- China
- Prior art keywords
- cell
- delivery system
- fta
- forsythoside
- exos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5068—Cell membranes or bacterial membranes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110225171.4A CN112999190B (zh) | 2021-03-01 | 2021-03-01 | A549细胞来源外泌体装载连翘酯苷a递药系统及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110225171.4A CN112999190B (zh) | 2021-03-01 | 2021-03-01 | A549细胞来源外泌体装载连翘酯苷a递药系统及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112999190A CN112999190A (zh) | 2021-06-22 |
CN112999190B true CN112999190B (zh) | 2022-06-10 |
Family
ID=76387389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110225171.4A Active CN112999190B (zh) | 2021-03-01 | 2021-03-01 | A549细胞来源外泌体装载连翘酯苷a递药系统及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112999190B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115845066A (zh) * | 2023-02-10 | 2023-03-28 | 深圳市第二人民医院(深圳市转化医学研究院) | 一种外泌体药物递送系统及其制备方法和应用 |
CN116236473A (zh) * | 2023-03-17 | 2023-06-09 | 成都中医药大学 | 一种抗肝纤维化的药物组合物及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512371A (zh) * | 2012-01-09 | 2012-06-27 | 北京农学院 | 一种连翘酯苷脂质体的制备方法 |
CN106176787A (zh) * | 2015-04-23 | 2016-12-07 | 富力 | 连翘苷、连翘苷衍生物、连翘苷与连翘脂素组合物在制备抗癌或抗肿瘤药物中的应用及药物 |
CN107913408A (zh) * | 2017-11-16 | 2018-04-17 | 中南大学 | 一种外泌体‑核酸适配体脂质体复合载药系统及其制备方法和应用 |
CN110123839A (zh) * | 2018-02-02 | 2019-08-16 | 上海睿泰生物科技股份有限公司 | 负载光敏药物的人多能干细胞外泌体及制备与用途 |
CN110152015A (zh) * | 2018-02-11 | 2019-08-23 | 上海市第六人民医院东院 | 负载抗肿瘤药物的人多能干细胞外泌体及其制备方法与用途 |
CN110604813A (zh) * | 2018-06-14 | 2019-12-24 | 深圳市人民医院 | 一种肿瘤细胞来源外泌体抗原在dc疫苗中的应用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2297343A1 (en) * | 2008-05-16 | 2011-03-23 | New England Biolabs, Inc. | Enzyme reagents for amplification of polynucleotides in the presence of inhibitors |
US11000593B2 (en) * | 2016-01-08 | 2021-05-11 | The Regents Of The University Of California | Cellular or viral membrane coated nanostructures and uses thereof |
KR20200142045A (ko) * | 2018-04-10 | 2020-12-21 | 브레인스톰 셀 세라퓨틱스 리미티드 | 세포 타입 특이적인 엑소좀 및 그 용도 |
-
2021
- 2021-03-01 CN CN202110225171.4A patent/CN112999190B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102512371A (zh) * | 2012-01-09 | 2012-06-27 | 北京农学院 | 一种连翘酯苷脂质体的制备方法 |
CN106176787A (zh) * | 2015-04-23 | 2016-12-07 | 富力 | 连翘苷、连翘苷衍生物、连翘苷与连翘脂素组合物在制备抗癌或抗肿瘤药物中的应用及药物 |
CN107913408A (zh) * | 2017-11-16 | 2018-04-17 | 中南大学 | 一种外泌体‑核酸适配体脂质体复合载药系统及其制备方法和应用 |
CN110123839A (zh) * | 2018-02-02 | 2019-08-16 | 上海睿泰生物科技股份有限公司 | 负载光敏药物的人多能干细胞外泌体及制备与用途 |
CN110152015A (zh) * | 2018-02-11 | 2019-08-23 | 上海市第六人民医院东院 | 负载抗肿瘤药物的人多能干细胞外泌体及其制备方法与用途 |
CN110604813A (zh) * | 2018-06-14 | 2019-12-24 | 深圳市人民医院 | 一种肿瘤细胞来源外泌体抗原在dc疫苗中的应用方法 |
Non-Patent Citations (5)
Title |
---|
Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics;Kim et al.;《International Journal of Molecular Science》;20201222;第22卷;第14页 * |
Exosomes: The next generation of endogenous nanomaterials for advanced drug delivery and therapy;Liao et al.;《Acta Biomaterialia》;20181228;第86卷;第1-14页 * |
Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs;Qiao et al.;《Theranostics》;20200210;第10卷(第8期);第3474-3487页 * |
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy;Yong et al.;《Nature Communications》;20190823;第10卷;第3838页 * |
外泌体装载连翘酯苷A递药系统的制备及体外评价;余亚辉等;《中国中药杂志》;20210304;第1-8页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112999190A (zh) | 2021-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gupta et al. | Dosing extracellular vesicles | |
Wang et al. | Challenges in the development and establishment of exosome-based drug delivery systems | |
Butreddy et al. | Exosomes as naturally occurring vehicles for delivery of biopharmaceuticals: insights from drug delivery to clinical perspectives | |
CN112999190B (zh) | A549细胞来源外泌体装载连翘酯苷a递药系统及其应用 | |
CN109507418B (zh) | 具有仿细胞结构的磁性纳米粒子、免疫磁性纳米粒子及其制备方法与应用 | |
CN106692181B (zh) | 纳米硒作为cik细胞增敏剂的应用 | |
CN110152015A (zh) | 负载抗肿瘤药物的人多能干细胞外泌体及其制备方法与用途 | |
US20210128472A1 (en) | Extracellular vesicles derived from osteoblast lineage cells for therapeutic and diagnostic use | |
CN112957478B (zh) | 一种细胞外囊泡(EVs)表面修饰靶向配体的方法 | |
Lu et al. | Evaluation of a new magnetic bead as an integrated platform for systematic CTC recognition, capture and clinical analysis | |
Xu et al. | Exploring the potential of exosomes in diagnosis and drug delivery for pancreatic ductal adenocarcinoma | |
Zhou et al. | Small extracellular vesicles: non-negligible vesicles in tumor progression, diagnosis, and therapy | |
Zhu et al. | Immuno-affinitive supramolecular magnetic nanoparticles incorporating cucurbit [8] uril-mediated ternary host-guest complexation structures for high-efficient small extracellular vesicle enrichment | |
CN109745326B (zh) | 一种包含吉非替尼和组蛋白去乙酰酶抑制剂的药物组合物,其脂质体制剂及其制药用途 | |
CN114225044B (zh) | 一种修饰细胞外囊泡的试剂及制备方法 | |
CN112237583A (zh) | 一叶萩碱链连二聚化合物sn3-l6或其药用盐在制备抗白血病药物中的应用 | |
Bjerkvig et al. | Anti-GM2 monoclonal antibodies induce necrosis in GM2-rich cultures of a human glioma cell line | |
CN112569362B (zh) | 一种通过打散ctc细胞团抑制肿瘤转移的方法 | |
CN112957341B (zh) | Mhs细胞来源外泌体装载连翘苷递药系统及其应用 | |
Lyu et al. | Functional evaluation of dendritic cells and extracellular vesicles as immunotherapy for breast cancer | |
Unsgaard et al. | A new technique to register proliferation of clonogenic cells from brain tumors | |
Liu et al. | Exploring Application in Lung Cancer Treatment Evaluation via Construction of Exosomes/CTCs Isolation and Identification System and Determination of Hypoxia-Inducible Factor-1α/FGFR | |
Fridman et al. | The Purification and Characterization of Exosomes from Macrophages | |
CN114522252B (zh) | 一步法叠氮化修饰细胞外囊泡的方法及修饰试剂 | |
CN116143934B (zh) | 一种干细胞外泌体提取试剂盒及其应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Haiying Inventor after: Shi Yanbang Inventor after: Guo Hui Inventor after: Yu Yahui Inventor after: Lv Tiantian Inventor after: Xue Bingquan Inventor after: Yu Haiyan Inventor before: Huang Haiying Inventor before: Shi Yanbang Inventor before: Guo Hui Inventor before: Yu Yahui Inventor before: Lv Tiantian Inventor before: Xue Bingquan Inventor before: Yu Haiyan |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant |